News & Updates

Show Multimedia Only

Prevention strategies for invasive meningococcal infections in the APAC region

01 Apr 2025 by

Invasive meningococcal disease (IMD) presents a significant burden to many nations in the Asia-Pacific (APAC) region. At the 11^thAsian Congress of Pediatric Infectious Diseases (ACPID) 2024, Dr Mike Kwan, President of the Asian Society for Pediatric Infectious Diseases (ASPID), Board Member (ASPID) of the World Society for Pediatric Infectious Diseases (WSPID), and Standing Committee Member (East Asia) of the Asia Pacific Pediatric Association (APPA), presented an overview of local and international epidemiology data of IMD and discussed the effectiveness of meningococcal vaccines and challenges in overcoming vaccine hesitancy. He also shared key recommendations for prevention strategies proposed by experts from the APAC region.

Prevention strategies for invasive meningococcal infections in the APAC region

01 Apr 2025

Better NPC risk stratification with identification of distinct EBV DNA molecular features

01 Apr 2025 by

A research team from the Faculty of Medicine, Chinese University of Hong Kong (CUHK) has identified molecular features in Epstein-Barr virus (EBV) DNA specifically associated with nasopharyngeal cancer (NPC) that differ significantly from the EBV DNA found in individuals with general EBV infections.

Better NPC risk stratification with identification of distinct EBV DNA molecular features

01 Apr 2025

Adjunctive dexamethasone lowers death risk in hospitalized children with pneumococcal meningitis

31 Mar 2025

In the treatment of children hospitalized with pneumococcal meningitis, administering dexamethasone within 12 hours of initiating antibiotics appears reduce the 30-day risk of death, according to a retrospective study.

Adjunctive dexamethasone lowers death risk in hospitalized children with pneumococcal meningitis

31 Mar 2025

Vitamin D supplementation offers no protection against acute respiratory infections

30 Mar 2025

Taking vitamin D supplements does not appear to help reduce the risk of acute respiratory infections (ARIs) contrary to previous report, according to an updated meta-analysis.

Vitamin D supplementation offers no protection against acute respiratory infections

30 Mar 2025

Vaccination of vulnerable patients can reduce infection-associated CV risks

28 Mar 2025 by

The elderly and patients with chronic conditions have increased susceptibility to viral infections such as herpes zoster (HZ) and respiratory syncytial virus (RSV), as well as higher risks of cardiovascular (CV) and other complications due to infection. At a recent symposium, Professor Timothy Tan of the Westmead and Blacktown Hospitals, and Western Sydney University, Sydney, Australia, shared insights on how the recombinant adjuvanted RSV vaccine (RSVPreF3) and recombinant zoster vaccine (RZV) can play an important role in preventing these infections, particularly in older individuals and those with comorbidities, thereby mitigating infection-associated risks.

Vaccination of vulnerable patients can reduce infection-associated CV risks

28 Mar 2025

Is ED a long COVID symptom?

27 Mar 2025 by

A secondary analysis of CORES II* has shown that nearly a fifth of Japanese men hospitalized for COVID-19 developed symptoms of erectile dysfunction (ED) up to 2 years following the infection.

Is ED a long COVID symptom?

27 Mar 2025

Donepezil does little to improve post–COVID-19 fatigue, psychological symptoms

27 Mar 2025

Treatment with the acetylcholinesterase inhibitor donepezil hydrochloride falls short of improving post–COVID-19 conditions such as fatigue and psychological symptoms, as shown in a study from Japan.

Donepezil does little to improve post–COVID-19 fatigue, psychological symptoms

27 Mar 2025

DOR/ISL noninferior to comparator ARTs in two phase III trials

25 Mar 2025 by

In adults with virologically suppressed HIV-1* infection, switching to a two-drug regimen of doravirine 100 mg and islatravir 0.25 mg (DOR/ISL) was noninferior to continuing bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) or other baseline antiretroviral therapy (bART) regimens in maintaining viral suppression at 48 weeks, according to two phase III trials presented at CROI 2025.

DOR/ISL noninferior to comparator ARTs in two phase III trials

25 Mar 2025

More syphilis cases picked up with universal vs targeted ED screening

24 Mar 2025 by

Relying on targeted screening models for syphilis in emergency departments (EDs) leaves a substantial number of active cases undetected, new research shows.

More syphilis cases picked up with universal vs targeted ED screening

24 Mar 2025

Prenatal BPG delivery: 9-day treatment interval linked to higher risk of congenital syphilis

23 Mar 2025

When treating late latent syphilis during pregnancy, extending the interval between benzathine penicillin G (BPG) doses to 9 days may put newborns at risk of congenital infection relative to 6–8-day intervals, according to new research.

Prenatal BPG delivery: 9-day treatment interval linked to higher risk of congenital syphilis

23 Mar 2025

News & Updates

Filter by Specialty:

Specialty:

Prevention strategies for invasive meningococcal infections in the APAC region

Prevention strategies for invasive meningococcal infections in the APAC region

Better NPC risk stratification with identification of distinct EBV DNA molecular features

Better NPC risk stratification with identification of distinct EBV DNA molecular features

Adjunctive dexamethasone lowers death risk in hospitalized children with pneumococcal meningitis

Adjunctive dexamethasone lowers death risk in hospitalized children with pneumococcal meningitis

Vitamin D supplementation offers no protection against acute respiratory infections

Vitamin D supplementation offers no protection against acute respiratory infections

Vaccination of vulnerable patients can reduce infection-associated CV risks

Vaccination of vulnerable patients can reduce infection-associated CV risks

Is ED a long COVID symptom?

Is ED a long COVID symptom?

Donepezil does little to improve post–COVID-19 fatigue, psychological symptoms

Donepezil does little to improve post–COVID-19 fatigue, psychological symptoms

DOR/ISL noninferior to comparator ARTs in two phase III trials

DOR/ISL noninferior to comparator ARTs in two phase III trials

More syphilis cases picked up with universal vs targeted ED screening

More syphilis cases picked up with universal vs targeted ED screening

Prenatal BPG delivery: 9-day treatment interval linked to higher risk of congenital syphilis

Prenatal BPG delivery: 9-day treatment interval linked to higher risk of congenital syphilis